Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

NVIDIA and Lilly to invest $1B in AI lab to accelerate drug discovery with BioNeMo, robotics, and large-scale biomedical ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

In numerous scientific fields, high-throughput experimentation methods combined with artificial intelligence (AI) show great promise to accelerate innovation and scientific discovery.

Weighing innovation, reputation, business value, cost, integration overhead, and peer use, among other criteria, CISOs list ...

CES is the world’s most powerful ground for innovation. CES 2026 moved from theory to practical application of how technology ...

The advancement of artificial intelligence (AI) algorithms has opened new possibilities for the development of robots that ...

AI labs just can't get their employees to stay put. Yesterday’s big AI news was the abrupt and seemingly acrimonious ...

By integrating NVIDIA’s digital twins, foundation models and perception AI, Multiply Labs is pioneering a new era of robotic ...

Let's discuss four trends that will redefine how robots create value — from smarter math and cooperative behaviors to ...

X Square Robot has raised $140 million to build the WALL-A model for general-purpose robots just four months after raising ...

Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies ...